Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
07/2003
07/17/2003US20030134356 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134355 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134354 Vectors with DNA encoding pro polypeptides
07/17/2003US20030134344 Her2 gene amplification as detected by fluorescence in situ hybridization
07/17/2003US20030134338 Antibody that selectively binds to an ectodermally-derived stem cell; diagnosis of a neoplasm
07/17/2003US20030134327 Polypeptides fused to heterologous polypeptide sequences, antibodies which bind these polypeptides
07/17/2003US20030134325 Modified phycobilisomes and uses therefore
07/17/2003US20030134319 Amino acid sequences of peptides that are encoded by genes within the human genome, the kinase peptides
07/17/2003US20030134315 Testing a sample from a cancer patient for the expression of a negative signal transduction factor (NSTF) and for the expression of a positive signal transduction factor (PSTF), selecting chemotherapeutic agent for treatment based on above
07/17/2003US20030134306 Human and murine cytokine polypeptides
07/17/2003US20030134284 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030133971 Positively charged and neutral lipids facilitates cellular uptake; liposomes
07/17/2003US20030133939 Binding domain-immunoglobulin fusion proteins
07/17/2003US20030133938 Antibody-avidin fusion proteins as cytotoxic drugs
07/17/2003US20030133937 Incubating the biological preparation with a saccharide, a glycoconjugate or an antibody that inhibits the binding of malignant cells expressing sialyl Lea or di-sialyl Lea, to endothelial cells expressing a LEC-CAM (selectin)
07/17/2003US20030133936 Modulating glucocorticoid induced tumor necrosis factor receptor (GITR) with an agent (antibody, a small molecular agonist antagonist antibodies) that binds GITR to potentiate regulatory T cell function
07/17/2003US20030133935 Administering to the human an effective (tumor necrosis factor)TNF- inhibiting amount of an anti-TNF chimeric antibody, which competitively inhibits binding of TNF to monoclonal antibody cA2
07/17/2003US20030133934 Method for enhancing the presentation of exogenous antigen by human antigen-presenting cells and opsonized micro particle complexes for applying this method
07/17/2003US20030133933 Novel integrin alpha subunit
07/17/2003US20030133932 Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents
07/17/2003US20030133931 Combining a putative modulator compound of mammalian histamine H4 receptor protein activity with mammalian histamine H4 receptor protein and a known histamine receptor H4 ligand, measuring the effect of the modulator on the protein
07/17/2003US20030133930 Administering to a patient having an autoimmune disorder an antibody to a B-cell antigens and a carrier; CD22, CD20, CD19, and CD74 or HLA-DR antigen.
07/17/2003US20030133874 Analytical method to evaluate animal models of neurofibrillary degeneration
07/17/2003CA2767061A1 Specific binding agents of human angiopoietin-2
07/17/2003CA2513287A1 Multispecific binding molecules
07/17/2003CA2473226A1 Diagnostics and vaccines for mycrobacterium paratuberculosis infections
07/17/2003CA2472927A1 A novel splice variant of myd88 and uses thereof
07/17/2003CA2472893A1 Cancer treatment
07/17/2003CA2472826A1 Antibodies directed to pdgfd and uses thereof
07/17/2003CA2472383A1 Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor
07/17/2003CA2472154A1 Use of antibodies against the muc18 antigen
07/17/2003CA2472111A1 Human mast cell-expressed membrane proteins
07/17/2003CA2471938A1 Agent for treating arthritis
07/17/2003CA2471936A1 Methods for using anti-muc18 antibodies
07/17/2003CA2471868A1 Methods of generating multispecific, multivalent agents from vh and vl domains
07/17/2003CA2471849A1 Antibodies against the muc18 antigen
07/17/2003CA2471840A1 Novel compositions and methods for cancer
07/17/2003CA2471551A1 Methods to engineer mammalian-type carbohydrate structures
07/17/2003CA2471432A1 Nonhuman model animal lacking the ability to control lymphocyte migration
07/17/2003CA2471431A1 Compositions and methods for the diagnosis and treatment of tumor
07/17/2003CA2471214A1 The use of histamine h4 receptor antagonist for the treatment of inflammatory response
07/17/2003CA2470012A1 Novel proteins and nucleic acids encoding same
07/17/2003CA2469177A1 Insulin-responsive dna binding protein-1 and methods to regulate insulin-responsive genes
07/17/2003CA2468888A1 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof
07/17/2003CA2467084A1 Mutant chromophores/fluorophores and methods for making and using the same
07/17/2003CA2467083A1 Viral capsid assembly intermediates
07/16/2003EP1327685A1 Bzip transcripiton factors that controls expression of the storage protein in the rice plant
07/16/2003EP1327681A1 Degraded agonist antibody
07/16/2003EP1327680A1 Degraded tpo agonist antibody
07/16/2003EP1327147A2 Neurotransmission disorders
07/16/2003EP1326998A2 Cd38 modulated chemotaxis
07/16/2003EP1326987A1 Chimeric cytoplasmic signalling molecules derived from cd137
07/16/2003EP1326985A1 Identification of a human n-terminal acetyltransferase gene
07/16/2003EP1326978A2 Hematopoietin receptors hpr1 and hpr2
07/16/2003EP1326976A1 Mfq-114, a human ajuba like protein
07/16/2003EP1326974A2 Methods of using a human il-17-related polypeptide to treat disease
07/16/2003EP1326972A2 Transporters and ion channels
07/16/2003EP1326971A2 Proteins and nucleic acids encoding same
07/16/2003EP1326967A2 Novel aggrecanase molecules
07/16/2003EP1326897A2 Humanized anti-lt-beta-r antibodies
07/16/2003EP1326896A2 Human anti-cd40 antibodies
07/16/2003EP1326895A1 Monoclonal antibodies directed against hepatitis b viruses
07/16/2003EP1326894A2 Novel tumor-associated marker
07/16/2003EP1326893A2 Plasma fraction containing bikunin, method for the production thereof and use of the same
07/16/2003EP1326891A1 Gene encoding a human g-protein coupled receptor and its use
07/16/2003EP1326888A2 Novel compounds
07/16/2003EP1326887A2 Polypeptide from haemophilus influenza
07/16/2003EP1326886A2 Basb208 nucleotide and amino acid sequences from haemophilus influenzae
07/16/2003EP1326885A2 Novel compounds
07/16/2003EP1075513A4 Continuous in vitro evolution
07/16/2003EP1019510B1 Vaccines derived from porcine circoviruses
07/16/2003EP0873353B1 IgG SEPARATION MEDIUM AND PROTEIN A VARIANT
07/16/2003EP0852586B1 Use of a 24 kDa protein for treating and diagnosing an HCV Infektion
07/16/2003EP0801658B1 Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples
07/16/2003EP0759935B1 Recombinant papilloma virus l1
07/16/2003EP0743856B1 Antigen-based heteropolymers for treating autoimmune diseases
07/16/2003CN1429844A Method and kit for detecting, or determining, 3,4-methylenedioxymethamphetamine
07/16/2003CN1429843A Gene reform immune globulin with low immunogenicity and its application
07/16/2003CN1429841A New human protein having mouse NIH/3T3 cell conversion promoting function and its code sequence
07/16/2003CN1429840A New human protein having cancer cell growth in hibiting function and its code sequence
07/16/2003CN1429839A New human protein having cancer inhibiting function and its code sequence
07/16/2003CN1114619C Preparation method of liver cancer murine monoclone antibody of mouse hybridoma strain Hepama-1 secretory
07/15/2003US6593461 Isolated DNA of given nucleotide sequence which encodes an amino acid sequence; hybridization; use in diagnosing, preventing and treating gastrointestinal disorders
07/15/2003US6593458 Antibody for use in the treatment of cancer
07/15/2003US6593456 Polypeptide for use in the treatment rheumatoid arthritis
07/15/2003US6593297 Compounds and methods for inhibiting cancer metastasis
07/15/2003US6593137 Antibodies specific for fullerenes
07/15/2003US6593135 Quantitative analysis
07/15/2003US6593133 Neurotrophic factors
07/15/2003US6593121 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of nervous system disorders
07/15/2003US6593119 Core 2 β-1,6-N-acetylglycosaminyltransferase gene
07/15/2003US6593112 Polynucleotides encoding fibroblast growth factor 15
07/15/2003US6593108 Nucleic acid molecule encoding a melanin-concentrating hormone receptor 2 polypeptide
07/15/2003US6593105 Vector comprising a nucleic acid insert; alteration of amino acids within the helix-1 region; inability to convert to a disease-associated form; use in prophylaxis/gene therapy for neurodegenerative diseases
07/15/2003US6593098 Genes encoding proteins involved in mitotic checkpoint control and methods of use thereof
07/15/2003US6593081 Production of anti-self antibodies from antibody segment repertoires and displayed on phage
07/15/2003US6593080 Diagnosis, prevention and treatment of calicivirus infection in humans
07/15/2003US6593079 Method for simultaneous detection of HIV antigens and HIV antibodies
07/15/2003US6592873 Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids
07/15/2003US6592871 Partial sequences of the C-100-3 and env/core with C-regions
1 ... 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 ... 1494